A Study to Determine Preferences Towards Interface Products

NCT ID: NCT03948152

Last Updated: 2020-07-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

310 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-18

Study Completion Date

2020-02-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Enrolled Naïve participants will be randomized to one of two arms, the investigational or control arm. Once randomized the institutions will fit the participant with the procedures outlined in the protocol. Each participant will be required to trial the mask for a period of 90 days. Any Unscheduled Visits or Calls that occur during the participants 90 days documented.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Disorder; Breathing-Related

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard of Care

Group Type ACTIVE_COMPARATOR

Standard of Care

Intervention Type OTHER

Participants will have a Positive Airway Pressure (PAP) mask chosen to wear for a period of 90 days as provided by the sites standard of care.

Mask Advice Tool

Group Type EXPERIMENTAL

Mask Advice Tool

Intervention Type OTHER

Participants will have a Positive Airway Pressure (PAP) mask chosen to wear for a period of 90 days as provided by the mask advice tool.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard of Care

Participants will have a Positive Airway Pressure (PAP) mask chosen to wear for a period of 90 days as provided by the sites standard of care.

Intervention Type OTHER

Mask Advice Tool

Participants will have a Positive Airway Pressure (PAP) mask chosen to wear for a period of 90 days as provided by the mask advice tool.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult Volunteers (ages 21-85)
* Willing and able to provide informed consent
* Able to follow instructions
* Able to read and speak in English as their primary language
* Currently diagnosed with Sleep Apnea through an in-lab sleep (polysomnography (PSG)) or home sleep testing, but has not started therapy and/or been fit with a mask.

Exclusion Criteria

* Pre-existing conditions such as bullous lung disease, pathologically low blood pressure, bypassed upper airway, pneumothorax, pneumocephalus, cerebral spinal fluid (CSF) leaks, cribriform plate abnormalities, and prior history of head trauma that has resulted in current cognitive dysfunction.
* Prescribed an Adaptive Servo Ventilation (ASV) device
* The presence of physical or mental limitations that would limit the ability to test the mask.
* Obstructive Sleep Apnea (OSA) diagnosis achieved through a split night sleep study
* Known allergy to silicone
* Unique facial features (i.e. deformities of the face and/or head, piercings, etc) that could interfere with the use of masks.
* Employee of Philips or spouse of a Philips employee
* Currently participating in another interventional research study or planned participation in another interventional research study during the trial period (by self-report)
* Surgery involving the eyes, ears, nose, sinuses, or upper airway within the last 90 days.
* Planned surgical procedures involving the head, neck, face (eyes, ears, nose), or lung during the trial period.
* Uncontrolled or poorly managed gastroesophageal reflux
* Impaired cough reflex
* Untreated or symptomatic hiatal hernia
* Untreated glaucoma
* Untreated chronic dry eyes
* Unable to remove the sleep apnea mask without the assistance of others
* Use of prescription drugs that induce vomiting
Minimum Eligible Age

21 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Philips Respironics

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pulmonary Disease Specialists, PA, d/b/a PDS Research

Kissimmee, Florida, United States

Site Status

Center for Sleep and Wake Disorders

Chevy Chase, Maryland, United States

Site Status

Pullmonary Rehabilition Associates

Youngstown, Ohio, United States

Site Status

Berks Schuylkill Respiratory Specialists, Ltd.

Reading, Pennsylvania, United States

Site Status

Bogan Sleep Consultants, LLC

Columbia, South Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SRC-SLE(PI)-CP-2018-10129

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Narcolepsy Nightmare Study
NCT05709873 COMPLETED NA
Apnea and Insomnia Relief Study
NCT04007796 COMPLETED PHASE2